INJ price gears up for a potential 60% surge ahead of EVM mainnet launch

INJ price is currently testing a key breakout level after surging above $15.50, with a potential 60% rally in sight as momentum builds ahead of Injective’s upcoming EVM mainnet launch.

Injective (INJ) price is currently in the middle of a breakout from an ascending triangle pattern on the daily chart, having pushed through horizontal resistance at $15.50 and reached an intraday high of $15.85 today. The move follows a bullish crossover between the 50-day SMA and the 20-day EMA, which remains intact. The 20-day EMA has continued to act as dynamic support, containing the recent pullback from last week’s failed breakout attempt.

While there is still a chance this breakout fails like the previous one—with the price just wicking above the upper boundary of the ascending triangle resistance before falling back inside the pattern—technical indicators currently lean toward a breakout follow-through scenario.

RSI is at 68, approaching overbought territory but still leaving room for a daily close above the triangle. MACD is also bullish, with the MACD line above the signal line and the histogram printing rising green bars.

If INJ price closes above $15.50, it opens the door for a potential move toward $26, based on the measured move from the height of the ascending triangle.

What’s driving INJ breakout?

INJ price breakout is unfolding alongside major fundamental news for the project, as the team has just announced the successful internal deployment of its native EVM mainnet. This milestone comes less than a month after the EVM testnet went live on July 3. Once publicly launched, it will allow developers to deploy Ethereum-compatible decentralized applications directly on Injective’s Layer 1 blockchain.

It’s also worth noting that Injective added SBET to its expanding suite of on-chain offerings, which dominated headlines last Friday. SBET — the world’s first on-chain digital asset treasury — tokenizes SharpLink Gaming’s $1 billion ETH treasury into a tradable, yield-generating asset built using Injective’s iAssets framework.